Genentech, Phenomix Enter Immune Disorder Target Deal July 13, 2004 By Kim Coghill Genentech Inc. signed a multiyear collaboration with Phenomix Corp. to identify and prioritize drug targets for immune disorders. (BioWorld Today)Read More
RSS